These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Plontke SK, Löwenheim H, Mertens J, Engel C, Meisner C, Weidner A, Zimmermann R, Preyer S, Koitschev A, Zenner HP. Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627 [Abstract] [Full Text] [Related]
6. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Plaza G, Herráiz C. Otolaryngol Head Neck Surg; 2007 Jul; 137(1):74-8. PubMed ID: 17599569 [Abstract] [Full Text] [Related]
7. [The effect of intratympanic dexamethasone or methylprednisolone on treatment of sudden sensorineural hearing loss]. Yang J, Huang L, Shi J, Li Y, Wu H, Kong W. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jul; 24(13):594-7. PubMed ID: 20842947 [Abstract] [Full Text] [Related]
8. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss. Park MK, Lee CK, Park KH, Lee JD, Lee CG, Lee BD. Otolaryngol Head Neck Surg; 2011 Dec; 145(6):1016-21. PubMed ID: 21817157 [Abstract] [Full Text] [Related]
9. Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss. Gouveris H, Schuler-Schmidt W, Mewes T, Mann W. Otol Neurotol; 2011 Jul; 32(5):756-60. PubMed ID: 21646933 [Abstract] [Full Text] [Related]